What We're Reading: Page 279
Industry reads hand-picked by our editors
Feb 05, 2018
Feb 02, 2018
-
The Denver Post
Big pharma may own Washington, but it doesn't own Amazon
-
Bloomberg
Fosun's $1.5 billion biotech arm mulls Hong Kong IPO
-
Wired
Could a vaccine protect football players from concussions?
-
CNBC
Pharma's latest defense: Drugs lower health-care costs
-
Forbes
Blockchain technologies poised to disrupt stagnant trial timelines
Feb 01, 2018
-
Bloomberg Gadfly
AbbVie is ruining pharma earnings season
-
Wired
Big pharma has the flu
-
Scientific American
A big step toward a blood test for Alzheimer's
Jan 31, 2018
-
Kaiser Health News
Expert advice for the corporate titans taking on health care
-
Fortune
Female founders got 2% of venture capital dollars in 2017
-
The Wall Street Journal
Investor who rode pivot from biotech to Bitcoin sells big stake
-
The New York Times
Preventive care saves money? Sorry, it’s too good to be true
Jan 30, 2018
Jan 29, 2018
-
Reuters
How Sanofi's setback could lead to better dengue vaccines
-
Bloomberg
Hong Kong seeks to cash in on frenzy for Chinese drug stocks
-
Chemical & Engineering News
Uncovering the hidden signs of organ transplant rejection
Jan 26, 2018
-
NPR
An uncle's overdose spurs Medicaid official to change course
-
CBS
Patients seeking "death with dignity" face drug price-gouging
-
Genetic Engineering & Biotechnology News
Dopamine receptor–drug structure could aid development of safer antipsychotics
-
Time
This tiny implant can deliver medicine to your brain with the push of a button
Previous
